Veracyte, Inc.
VCYT
$58.94
$2.183.84%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | 88.01M | 66.35M | 30.32M | 26.34M | 33.05M |
| Total Depreciation and Amortization | 21.48M | 21.42M | 22.37M | 22.98M | 23.23M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 55.31M | 49.96M | 66.30M | 61.35M | 45.78M |
| Change in Net Operating Assets | 1.36M | -1.42M | -10.74M | -17.21M | -12.64M |
| Cash from Operations | 166.16M | 136.31M | 108.25M | 93.45M | 89.42M |
| Capital Expenditure | -10.82M | -9.68M | -10.04M | -9.49M | -10.97M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | 0.00 | 0.00 | 0.00 |
| Divestitures | -2.85M | -2.85M | -- | -- | -- |
| Other Investing Activities | -71.69M | 3.31M | -47.88M | -98.94M | -100.00M |
| Cash from Investing | -85.35M | -9.21M | -57.92M | -108.43M | -110.97M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 13.85M | 14.08M | 13.84M | 20.51M | 19.99M |
| Repurchase of Common Stock | -18.22M | -18.30M | -17.92M | -17.29M | -16.21M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -4.50M | -4.50M | -4.50M |
| Cash from Financing | -4.37M | -4.22M | -8.58M | -1.27M | -716.00K |
| Foreign Exchange rate Adjustments | 587.00K | 719.00K | 306.00K | 392.00K | -242.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 77.03M | 123.60M | 42.05M | -15.85M | -22.51M |